Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
CONTENTS
01 logos 3
02 packaging 5
03 photoshop work 18
04 leaflets 23
05 infographics 30
06 brochures 33
07 presentations 35
08 illustrations 41
09 animations 47
2
01 logos
3
logos
4
02 packaging
5
packaging
6
packaging
7
packaging
8
packaging
ENERGY | Drinks
9
packaging
10
packaging
11
packaging
Cadbury | Packaging
12
packaging
Cadbury | Packaging
13
packaging
Cadbury | Packaging
14
packaging
Foals | CD cover
15
packaging
16
packaging
17
03 photoshop
work
18
photoshop work
BEFORE AFTER
Healthy Beauty | Key visual – a client requested a contemporary neon light look and feel of movement
19
photoshop work
BEFORE AFTER
20
photoshop work
BEFORE AFTER
21
photoshop work
BEFORE AFTER
Photo recreation
22
04 leaflets
23
leaflets
24
leaflets
25
leaflets
KOSMET
• Submit an essay on cosmetic science, • To apply, scientist must have a paper
answering one of the questions published in the IFSCC Magazine in
posted on our website. 2020 or 2021. All papers and posters
presented at IFSCC
• Scientist must be 35 or younger on • Scientist must be 40 or younger on
Congresses and
the day they submit their essay. Essay the day the day they submit their
submission deadline is 1 June 2021 paper. Paper should be submitted by Conferences since 1995
For details, visit the Awards section of The IFSCC is grateful to our KOSMET
www.ifscc.org corporate sponsors: Greentech and Pechoin www.kosmet.com
IFSCC | A4 leaflets
26
leaflets
What is DHASCO®-B?
water-based process for infants
Organic compliant** Recognizing cost savings
to drive innovation DHASCO®-B
DHASCO ®
DHASCO®-B is vegetarian
40% DHASCO®-B contains 40% DHA
*Mehta et al, 2016; Yeiser et al, 2016. **Compliance may vary depending on regulatory standards. ***DSM estimate.
life’sDHA® and DHASCO® are trademarks of DSM.
27
leaflets
DEVELOPMENTS AT NESTLÉ
1934
Launch of Pelargon, a full-milk
powder for babies enriched with lactic
acid bacteria to improve its digestibility.
1936
Annales
1905
Nestlé launches the vitamin
1942
1867
Henri Nestlé invents Anglo-Swiss and Nestlé
the first Farine Lactée merge to form the Nestlé and supplement Nestrovit. Nestlé is
(’flour with milk’), for Anglo-Swiss Company. relaunched
infants who cannot as an 2017
1929
be breastfed. Nestlé adds vitamins A international
and D to infant cereals. journal 1972
covering all
1935
The Pediatric Journal Annales Nestlé fields of
appears in its original from, in French only. 1949 1985 1996
pediatrics.
1866
The Anglo-Swiss
Condensed Milk
Nestlé & Anglo-Swiss acquires Norwegian dairy 1959 2009
1916
Company opens the
company Egron, which has patented a
1954
first European
1948
Nestlé introduces infant cereal in Nestlé infant cereal is Nestlé launches the first infant
1961
condensed milk factory. spray-drying process for producing milk powder. the form of a powdered product. rebranded as Cerelac. formula with demineralized whey.
CONTINUED OVERLEAF
1965 Dermatological problems in children
treatment of critical pediatric conditions. The following timeline is a
premature babies
published, but our thanks go out to all the contributors and editors who have
1936
1906
1871
1881
1926
1891
1896
1946
1901
1921
1931
1876
1861
1916
1911
1941
Jacobi establishes the first pediatrics The Japan Pediatric Society is Archives of Disease in Childhood Del Mundo The Indian The WHO launches the Intensified
1926
1896
department at a general hospital established in Tokyo. in launched. establishes the Academy of Smallpox Eradication Programme.
first pediatrics Pediatrics is
1861
1963
1957
Jules Bordet Fleming discovers the Philippines. Mumbai.
1967
the rubella vaccine.
and Octave penicillin while studying
1928
whooping cough.
DEVELOPMENTS IN PEDIATRIC MEDICINE
1953
Popper identify Academy of Pediatrics of chickenpox. Ormond Street Hospital
1961
(London).
1908
1930
1910
1960
in 1869. diphtheria. Sabin, is licensed.
Burnet and Macnamara Organization
discover there is more (WHO) is
1931
1948
Theiler develops the first yellow The first heart and lung bypass
1936
1962
Ormond Street.
1963
Asperger publishes his definition of autistic measles vaccine.
1944
1890
1973 »
1961: Image courtesy of Nigel Cox
» 2018
28
leaflets
DEVELOPMENTS AT NESTLÉ
2002
1981
The Nestlé Nutrition Institute
2010
Nestlé is one of the first companies to Nestlé develops a unique process to Nestlé Health Science and the Nestlé
2011
Renamed Nestlé S.A.
1977
the company continues develop policies based on the WHO improve the protein quality and reduce becomes a not-for-profit Institute of Health Sciences are established.
its diversification strategy code on breast milk substitutes and to the protein content in infant formula. association based in Switzerland.
The Nestlé Annales Nestlé is indexed in PubMed.
1978
outside the nutrition apply them across its business.
1995
Nutrition Nestlé introduces the first Launch of the first Infant Feeding
sector.
2009
Council is Maternal Nutrition in pregnancy: eating infant formula with probiotics. and Toddlers Study. Inaugural
for two?, based on the workshop held Creating
2012
founded. Nestlé acquires Wyeth Nutrition,
in the previous year, is published. Shared
1997
Nestlé the infant formula division of Pfizer.
2006
becomes the Nestlé acquires American baby Value Forum,
leader in food manufacturer Gerber. which
becomes
2014
‘Nutrition, Nestlé acquires weight Creation of Nestlé Skin Health.
an annual
1980
The first Nestlé Nutrition Health and management business Jenny Craig.
Workshop is held in Vaucluse, France. Wellness’. event.
2017
Nestlé develops
Annales Nestlé is edited in 5 languages
2004
2007
1987
1996
Nestlé develops the first partially The Nest first Nestlé adds special fatty Nestlé acquires the Novartis formula with Human
(English, French, German, Spanish, Portuguese). hydrolyzed infant formula. appears, in English. acids to infant formula. Medical Nutrition business. Milk Oligosaccharides.
functional effects
1981 Obesity in infants
1976 Pediatric urology
2012 Nutrigenetics
The first Fogarty Center Levinsky performs WHO confirms that HIV can be The first National The Scaling Up Nutrition (SUN)
International Conference the UK’s first bone passed from mother to child Immunization Days against movement releases ‘Scaling Up UN Secretary-General Ban
2009
1998
on Obesity is held in marrow transplant polio begin in Sudan. Nutrition – what will it cost?’ Ki-moon launches the
1987
during breastfeeding.
1973
1979
2012
Maryland, USA. on a child. ‘Zero Hunger Challenge’.
A new alternative to
In the USA, a open heart surgery
Ima
ge
major advance in for children is
co
DEVELOPMENTS IN PEDIATRIC MEDICINE
urt
the prevention of invented at Great
esy o
2001
HIV infection is Ormond Street.
f Edward
achieved by
treating infected
mothers with
Th
o
m
zidovudine during
ps
on
1994
pregnancy.
2014
code of marketing of infant formula Medicine Ending Childhood Obesity.
and other products used as Switzerland
breast-milk substitutes, following (PEM) is
1981
2010
Switzerland.
2013
The 27th World Health Maternal and Child Nutrition.
Assembly establishes the
Expanded Programme on The First International The Lancet releases
Immunization. Conference on a milestone series of
The last case of indigenous Nutrition produces a The American Academy of Pediatrics finds that
The UN hosts the first polio in the Western Hemisphere papers on Maternal breastfeeding can help protect against sudden
World Declaration on
2008
2017
and Child Nutrition.
1974
1861 «
« 1972
29
05 infographics
30
infographics
1.2 million
orders received. 155 prescribers
orders have been received 4 million in Argentina.
after the product launch. sales contracted.
The DSM Nutrition Academy webinar on The presentation was very good.
“Essential nutrients for an effective Héctor Cori is very clear in his dissertations
LISTEN TO Premix experts visited FeiHe to
understand their product challenges
immune system” from 2nd of April was and the complex questions are solved in a
very clear way. I want to thank everyone for
CUSTOMERS and offered solutions for
the starting point of the project.
the collaboration to make this happen.
2 critical cases within
24 hours Mastellone team
No. 1 Chinese
ROMINA RIVEROS – Product Development Manager
joined the webinar and
ELN player As a result of DSM’s expertise and decided to develop a
OUTCOME
LOW-COST
proactiveness, FeiHe increased
our share from 20% to 40% and
NUTRITION
In 2018 DSM lost their New product launch
offered new projects.
share at FeiHe due to despite COVID scenario,
quality complaints. DSM is now considered
E PRODUCT, followed by a positive
In the past 2 years HX Operation THE ELN expert A available to the majority feedback from
team hasworked hard on C of the population the customer.
the improvements. Zn D in Argentina.
DSM | infographics
31
infographics
Vitamin
200-500 mg
C Vitamin
2,000 IU (50 μg)
D Omega-3 Zinc
250 mg 8-11 mg
To find the suitable products that contain these nutrients, please contact:
your your health trusted
pharmacist food store online outlets
World Health Organization Influenza (Seasonal). Available online: https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal)
Calder et al, ‘Optimal Nutritional Status for a Well-Functioning Immune System is an Important Factor to Protect Against Viral Infections’, Preprints 2020, 20200 30199.
Calder, ‘Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?’, Br J Clin Pharmacol, 2012.
Hemilä et al, ‘Vitamin C for preventing and treating pneumonia’, Cochrane Database of Systematic Reviews, 2013.
Hemilä, ‘Vitamin C and infections’, Nutrients, 2017.
Martineau et al, ‘Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data’, BMJ, 2017.
Gombart et al, ‘A review of micronutrients and the immune system–working in harmony to reduce the risk of infection’, Nutrients, 2020.
32
06 brochures
33
brochures
2 3
Catalysis technology
and specialty products
Solvias has an outstanding track record in the
successful implementation of catalysis
Our science
technology as well as the production of ligands
and other specialty products. We support our
customers with a library of over 700 ligands while
For two decades, the catalysis team at Solvias has been at the Separation of racemic mixtures by the formation and Solvias also has longstanding experience in the field of
forefront of innovation in the development of catalytic crystallization of diastereomeric salts (chiral resolution) is an heterogeneous catalysis and is able to develop highly
processes. We have begun exploring chemocatalysis as a tool important technology in the pharmaceutical industry. Solvias chemoselective processes, including those for very complex
of green chemistry to support more sustainable processes, offers HTE-assisted evaluations using a large variety of chiral and demanding molecules. One example is the successful
and recently extended our portfolio to integrate catalysts for acids and bases. Applying this methodology, Solvias has application of the Solvias amine monomethylation technology
photoredox catalysis and C-H activation. successfully resolved a large number of chiral customer for an improved synthesis of an API-intermediate, in which we
compounds. Close interaction with our solid state department developed a superior lab procedure and successfully
Flexible high throughput experimentation (HTE)
allows for further in-depth analyses towards scalable processes. demonstrated it on a kilogram scale.
arrangements, using the Symyx workflow based on dedicated
96-well plates, allow the team to identify optimal catalysts and A WORLD-LEADING LIGAND PORTFOLIO FOR
Explore the wide application range
conditions for customers’ reactions and substrates. Solvias CATALYTIC TRANSFORMATIONS
of our modular ligand families on the
uses the HTE platform to find leads for asymmetric Solvias has built one of the largest proprietary ligand
transformation, C-X coupling, heterogeneous hydrogenation LIGANDS & CATALYSTS
portfolios in the world to further support our customers’ INFORMATION PLATFORM
and miscellaneous catalytic reactions that can be adapted to catalytic transformations. The portfolio consists of a variety of
HTE protocols. Leads obtained from HTE projects can be http://ligands.solvias.com
families of chiral phosphine ligands for stereoselective
seamlessly optimized and developed by our experts, catalytic reactions, achiral phosphines and catalysts that can
culminating in a technology transfer to the client or kg be utilized for C-X coupling (e.g. the cataCXium ligand families)
scale-up in Solvias laboratories. as well as chiral phosphoric acid catalysts for use in
organocatalytic transformations. Based on in-house
development and licensing, all ligands and catalysts in the Solvias
portfolio are readily available for commercial-scale applications
and are sold IP included. Their performance (quality, chemical
stability, ease of handling, safety) and supply chain meet all
applicable pharmaceutical industry requirements.
18 19
34
07 presentations
35
presentations
DSM ELN | Open the link to see the full version: https://1drv.ms/p/s!AlQF1qqh4wqcgchOkp2jdWyrN8gY9g?e=0RBTNF
36
presentations
DSM Sales meeting | Open the link to see the full version: https://1drv.ms/p/s!AlQF1qqh4wqcgchIofPEK9zf7bRzrg?e=W7TkJh
37
presentations
DSM Services | Open the link to see the full version: https://1drv.ms/p/s!AlQF1qqh4wqcgchNMy1bvWdg2T4lag?e=gYsh0b
38
presentations
39
presentations
Comprehensive animation, fully created in PowerPoint | Open the link to see the full version: https://1drv.ms/p/s!AlQF1qqh4wqcgchMVPWAWox_AJhPLw?e=H0ulqh
40
08 illustrations
41
illustrations
42
illustrations
43
illustrations
44
illustrations
45
illustrations
46
09 animations
47
animations
48
animations
49